Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
. Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
. Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
. Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
. Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
URLs:
Website: https://go.evvnt.com/2357369-0?pid=11140
Virtual: https://go.evvnt.com/2357369-3?pid=11140
Prices:
Practicing Physician/Industry: USD 1495.00,
Military/Retired/Scientist/VA: USD 1295.00,
PA/Nurse: USD 1195.00,
Resident/Fellow: USD 1095.00,
Technologist: USD 995.00
Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don C. Yoo, MD
Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education)
Date and Time: 16th October 2025 at 7:30 am to 17th October 2025 at 4:45 pm
Additional Details
Event Email - [email protected]
Organizer
CME Science is dedicated to promoting and coordinating the development and dissemination of educational content that is relevant and meaningful to clinical practice and to serving the health care needs of the general public through the support of science, teaching, research and quality of service.
Venue
5-star hotel